• 5-HT3 Antagonists Inhibit Renal OCT2/MATE1: Implications for

  2026-05-09

  This article reviews recent in vitro evidence that 5-HT3 receptor antagonists, including Tropisetron Hydrochloride, can inhibit renal organic cation transporters OCT2 and MATE1. Understanding these transporter interactions informs both neuroscience receptor modulation studies and research on renal drug handling, revealing important considerations for pharmacology and drug-drug interaction research.

• Dextran Sulfate Sodium Salt: Optimizing DSS Colitis Models

  2026-05-08

  Dextran sulfate sodium salt (MW 35000-45000) enables robust, reproducible modeling of intestinal inflammation and epithelial repair in preclinical research. This article delivers actionable protocol insights, troubleshooting strategies, and highlights a breakthrough in decoding epithelial repair pathways using DSS models.

• (R,S)-Anatabine: Translating Amyloid Reduction to Clinical I

  2026-05-08

  This thought-leadership article dissects the mechanistic and strategic landscape for (R,S)-Anatabine, a potent amyloid-beta and NF-κB pathway modulator, in Alzheimer's disease research. Building on the latest mechanistic discoveries and comparative analyses, the article offers translational researchers actionable guidance for deploying (R,S)-Anatabine in both in vitro and in vivo models. By contextualizing APExBIO's offering within a broader experimental and precision medicine framework, the discussion advances beyond typical product summaries, highlighting the compound's unique features, evidence base, and future directions for neurodegeneration research.

• HDAC3-Mediated TPM3 De-2-Hydroxyisobutyrylation Regulates Va

  2026-05-07

  This study identifies histone deacetylase 3 (HDAC3) as a critical regulator of 2-hydroxyisobutyrylation on tropomyosin 3 (TPM3) at Lys141 in vascular smooth muscle cells, directly linking this posttranslational modification to abnormal vasoconstriction. The findings elucidate a novel epigenetic mechanism in vascular dysfunction and highlight new therapeutic avenues for hypertension.

• S Tag Peptide: Practical Guidelines for Protein Tagging Work

  2026-05-07

  S Tag Peptide addresses core challenges in recombinant protein detection, purification, and solubility by providing a highly soluble, antibody-compatible fusion tag. It is best used in workflows requiring efficient affinity-based purification and reliable detection, but should not be applied where organic solvent solubility or autonomous peptide folding is essential.

• Chlorpromazine: Mechanistic Gateways in Translational Neurop

  2026-05-06

  This thought-leadership article explores chlorpromazine’s multidimensional role in modern neuropharmacology research, bridging its foundational mechanisms as a dopamine D2 receptor antagonist with strategic guidance for translational researchers. Emphasis is placed on rigorous experimental design, leveraging recent insights from hepatic nanoparticle interaction studies to inform best practices and future directions in antipsychotic and antiemetic research. The article integrates evidence-based recommendations, protocol parameters, and unique perspectives that expand the narrative beyond conventional product literature.

• Brain-to-Spinal Circuits Modulate Mechanical Allodynia Later

  2026-05-06

  Huo et al. (2023) identify a specific brain-to-spinal circuit that determines both the laterality and duration of mechanical allodynia in mice. Their findings reveal that the hypothalamic dynorphin/spinal κ-opioid receptor pathway acts as a descending inhibitory system, offering new mechanistic insights for pain modulation research.

• AM251: Strategic Mechanisms for Translational Cannabinoid Re

  2026-05-05

  This in-depth article explores AM251, a potent CB1 receptor antagonist, as an advanced tool for translational researchers in neuroscience, metabolic disorders, and cell signaling. We examine mechanistic rationale, current experimental evidence, and strategic considerations for leveraging AM251 in preclinical and translational contexts, connecting recent findings in endocannabinoid modulation, pain, and neuropsychiatric research. Practical protocol guidance and a forward-looking outlook are included, ensuring this resource serves as both a scientific foundation and a roadmap for innovative research.

• LY2886721: Applied Workflows for BACE Inhibitor Research

  2026-05-05

  LY2886721 stands out as a benchmark oral BACE inhibitor, enabling precise, nanomolar-level modulation of amyloid beta production in advanced Alzheimer's research models. This guide details workflow optimizations, experimental troubleshooting, and workflow-driven protocol enhancements for leveraging LY2886721’s unique profile in translational neuroscience.

• LY-411575: Gamma-Secretase Inhibitor for Alzheimer's Researc

  2026-05-04

  LY-411575 from APExBIO stands out as a benchmark gamma-secretase inhibitor for precision modulation of amyloid beta and Notch signaling. Its unmatched potency, robust solubility, and validated workflow compatibility make it the tool of choice for researchers tackling complex questions in Alzheimer’s disease and cancer biology.

• ASCL1 Controls Nuclear Size in Neuronal Reprogramming via NU

  2026-05-04

  This study demonstrates that the transcription factor ASCL1 induces nuclear shrinkage during the direct conversion of human fibroblasts into neurons by suppressing NUP37 expression, a key component of the nuclear pore complex (NPC). These findings clarify the regulation of nuclear size during neuronal transdifferentiation, with implications for understanding nuclear remodeling in postmitotic neurons.

• Ceftolozane/Tazobactam: Advances Against Resistant Gram-Nega

  2026-05-03

  The referenced study provides a comprehensive evaluation of ceftolozane/tazobactam, a novel cephalosporin/beta-lactamase inhibitor that demonstrates enhanced activity against multidrug-resistant gram-negative pathogens. Its distinct pharmacokinetic and pharmacodynamic profiles have important implications for antibacterial research and clinical treatment strategies.

• Milk-Derived Vesicle Uptake Mechanisms in ISC Organoid Model

  2026-05-02

  This study establishes pig intestinal stem cell–based organoid models to dissect the uptake and functional impact of milk-derived extracellular vesicles (MEV). By mapping region-specific internalization pathways and MEV-driven gene expression changes, the research advances both the physiological relevance and mechanistic understanding of vesicle trafficking in the gut.

• URB597 (KDS-4103): Precision FAAH Inhibition for Neuroplasti

  2026-05-01

  URB597 (KDS-4103) empowers researchers to selectively inhibit FAAH, enabling reliable modulation of endocannabinoid signaling in pain, neuroinflammation, and neuroplasticity models. This guide translates recent mechanistic discoveries into actionable protocols, with troubleshooting insights for maximizing reproducibility and translational impact.

• Technical Guidance for FITC-Concanavalin A (ConA) Conjugate

  2026-05-01

  FITC-Concanavalin A (ConA) Conjugate offers a direct, fluorescence-based approach for detecting α-D-glucose and α-D-mannose residues on cell surfaces, supporting immunofluorescence staining and flow cytometry in glycobiology research. It is not suitable for non-carbohydrate targets or workflows outside of carbohydrate-specific detection and should be used strictly within its defined storage and stability parameters.

15109 records 1/1008 page Next 12345 下5页 Last page